Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHHSETH
Clin. transl. oncol. (Print)
; 24(5): 770-783, mayo 2022.
Article
in English
| IBECS
| ID: ibc-203780
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement. However, prospective studies with large enough cohorts are scarce, limiting the development of evidence-based thromboprophylaxis guidelines. The present position paper is addressed to all hematologists treating patients affected by hematologic neoplasms with the aim to provide clinicians with a useful tool for the prevention of VTE.
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Hematologic Neoplasms
/
Venous Thromboembolism
/
Anticoagulants
Limits:
Humans
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2022
Document type:
Article
Institution/Affiliation country:
Hospital Clinic/Spain
/
Hospital General Universitario de Alicante/Spain
/
Hospital Universitario Ramón y Cajal/Spain
/
Hospital Universitario de Salamanca/Spain
/
Hospital de La Santa Creu I Sant Pau/Spain
